MELANOMA STAGE III OR IV
Clinical trials for MELANOMA STAGE III OR IV explained in plain language.
Never miss a new study
Get alerted when new MELANOMA STAGE III OR IV trials appear
Sign up with your email to follow new studies for MELANOMA STAGE III OR IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy hopes to boost immune attack on Hard-to-Treat melanoma
Disease control OngoingThis study tests a new drug called BI-1607 combined with two existing immunotherapies (ipilimumab and pembrolizumab) for people with advanced melanoma that has spread or cannot be removed. The goal is to see if adding BI-1607 helps the immune system better destroy cancer cells. A…
Matched conditions: MELANOMA STAGE III OR IV
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 26, 2026 09:22 UTC
-
Melanoma survivors: could immunotherapy harm your heart years later?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether melanoma patients who had immunotherapy (immune checkpoint inhibitors) may have heart problems years later. Researchers will invite 60 people who finished treatment 2 to 10+ years ago to have heart tests. The goal is to see if this kind of long-term mo…
Matched conditions: MELANOMA STAGE III OR IV
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC